Tentative Program

BIT’s 5th Annual Congress and Exposition of
Molecular Diagnostics (CEMD-2012)

Theme: Landscape of Technologies, Market and Superstars

Time: December 2-4, 2012

Venue: Guangzhou Baiyun International Convention Center
 

Program Layout

Track 1: Breaking Research on Molecular Diagnostics (MDx)

Track 2: Current and Emerging Technologies of MDx

Track 3: Applications of Molecular Diagnostics

Track 4: MDx in Pharmaceutical Industry and Healthcare

Track 5: Young Investigators’ Forum


Keynote Forum
Time: 09:00-11:40, Dec. 2, 2012, (Saturday); Place: Foshan Hall, 2nd Floor, Block 2, GZBICC

Moderator

Dr. Peng Zhou, CSO, Rheonix, Inc., USA

09:00-09:10

Moderator's Introtuction

09:10-09:40

Title: Taking Cancer Genomics to the Single Cell Level
Dr. James B. Hicks, Research Professor and Director, Cold Spring Harbor Laboratory, USA

09:40-10:10

Title: Identification of Human Embryonic Stem Cells Using Signal Characteristic Analysis hE[SC]2AN

Dr. Hemchandra M. Shertukde, President, Diagnostic Devices Inc., USA
10:10-10:40

Title: HAAH(Human Aspartyl (Asparaginyl) β-Hydroxylase), a Cancer Tumor Marker, as Companion Diagnostic Strategy
Dr. Mahmood Moshiri, President/CEO, Panacea Global Inc., Canada

10:40-11:10

Title: Biomarkers in Drug Development, What is Now and What is Next
Dr. Karen Long, VP, Abbott Molecular Inc., USA

11:10-11:40

Title: Rheonix CARD® – From Technology Innovation to FDA Registration
Dr. Peng Zhou, CSO, Rheonix, Inc., USA

 

Track 1: Breaking Research on Molecular Diagnostics (MDx)
Topic 1: Major Challenges Facing Molecular Diagnostic Industries
Topic 2: Molecular Imaging, Chromosome Imaging and Molecular Medicine
Topic 3: Pharmacogenomics, Pharmacogenetics and Personalized Medicine
Topic 4: Metabolomics and Proteomic Technologies for Molecular Diagnostics


Track 1: Breaking Research on Molecular Diagnostics (MDx)

Time: 13:30-16:20, Dec. 2, 2012, (Sunday); Place: Room No. 3401, 4th Floor, Block 3, GZBICC

 

Chair

Dr. Richard M. Weinshilboum, Professor, Mayo Clinic College of Medicine, USA

Co-chair

Dr. Bhuwnesh Agrawal,Chief Medical Officer and Head of Asia Pacific, Vela Diagnostics, Singapore

 

13:30-13:55

Title: Phamacogenomics: Beyond Biomarkers
Dr. Richard M. Weinshilboum, Professor, Mayo Clinic College of Medicine, USA

13:55-14:20

Title: High Sensitivity Plasma Determination of Hepcidin, A Peptide Biomarker for Iron Metabolism, Using HPLC-Chip-ESI-MS
Dr. Jacques Crommen, Professor, University of Liege, Belgium

14:20-14:45

Title: Proteomic Analysis of the Cervicovaginal Fluid Leads to Identification of Biomarkers for Cervix Cancer
Dr.Xaveer Van Ostade, Professor, University of Antwerp, Belgium

14:45-15:10

Title: Delivering Your Success: Providing Service Platform for Molecular Testing
Dr. Alexander Lezhava, Director R&D, Dx assays, Singapore

15:10-15:30

Coffee Break

15:30-15:55

Title: Personalised Healthcare - Where are We Today and Where are We Heading?
Dr. Bhuwnesh Agrawal, Chief Medical Officer and Head of Asia Pacific, Vela Diagnostics, Singapore

15:55-16:20

Title: RNA, DNA and Protein Biomarker Discovery from the Same Tissue Biopsy
Dr. Richard Fekete, Sr. Manager, R&D, Life Technologies, USA


Track 2: Current and Emerging Technologies of MDx

Track 2: Current and Emerging Technologies of MDx

Time: 08:30-12:10, Dec. 3, 2012, (Monday); Place: Room No. 3401, 4th Floor, Block 3, GZBICC

 

Chair

Dr. Yi-Ming Liu, Professor, Jackson State University, USA

 

08:30-08:55

Title: Pulsed Electromagnetic Fields Non-Invasively Stimulate Stem Cell Expansion for Clinical and Regenerative Science Applications
Dr. Alfredo Franco-Obregón, Head, Swiss Federal Institute of Technology, Switzerland

08:55-09:20

Title: The Regulatory Role of THY1 On Other Putative Ovarian Tumor Suppressor Genes
Dr. Nancy Wang, Professor, Department of Pathology Director, Cytogenetics Laboratory, University of Rochester Medical Center, USA

09:20-09:45

Title: The Role of Automated Quantitative FISH in the Diagnosis of Cervical Cancer
Dr. Vittorio Grazioli, Head of Laboratories, CDI Centro Diagnostico Italiano S.p.A., Italy

09:45-10:10

Title: Design of Chemiluminescent Nanometer-sized Probes for Highly Sensitive Bioassays
Dr. Yi-Ming Liu, Professor, Jackson State University, USA

10:10-10:30

Coffee Break

10:30-10:55

Title: DNA Sensor for Medical Diagnostic: Use of Synthetic Biology
Dr. Raul Cuero, Scientist/Research Director, International Parks of creativity, Colombia

10:55-11:20

Title: Microchannel Flow Control, Electric Measurement, and Dielectrophoretic Manipulation to Analyze Single Cell Characteristics
Dr. Kazuyoshi Nakabe,Professor, Kyoto University, Japan

11:20-11:45

Title: On-chip SortTM: Cell Analyzing and Sorting System Using Disposable Microfluidic Chip and Air Pressure Control System
Dr. Kazuo Takeda, Director, On-chip biotechnologies, Co., Ltd., Japan

11:45-12:10

Title: Circulating Endothelial Cells in Chronic Renal Failure Rats
Dr. Hazilawati Hamzah,Senior Lecturer and Coordinator, Universiti Putra Malaysia, Malaysia


Track 3: Applications of Molecular Diagnostics
Track 3-1: Applications of Molecular Diagnostics

Topic 1: Infectious Disease Diagnostics

Topic 2: Inherited Disorders

Track 3-1: Applications of Molecular Diagnostics

Time: 13:30-15:30, Dec. 3, 2012, (Monday); Place: Room No. 3401, 4th Floor, Block 3, GZBICC

 

Chair

Dr. Jane SC Tsai, Deputy General Director, ITRI, Taiwan

 

13:30-13:50

Title: Clinical Applications of Genotyping
Dr. Jane SC Tsai, Deputy General Director, ITRI, Taiwan

13:50-14:10

Title: xTAG – A Multiple Molecular Diagnosis Platform
Mr. James Xing, Field Marketing Scientist, Luminex Corporation, China

14:10-14:30

Title: Strongyloides Venezuelensis Protein Used in the Epidemiological and Clinical Diagnosis of Human Strongyloidiasis
Dr. Eleuza Rodrigues Machado, Professor & Researcher, Brasilia University, Brazil

14:30-14:50

Title: Biomarker: Its Potential for the Detection and Prediction of Common Genetic Disorders
Dr. Subrata Kumar Dey, Director, West Bengal University of Technology, India

14:50-15:10

Title: Human Aspartyl (Asparaginyl) β-Hydroxylase (HAAH) Levels as an Indicator for Patients at Risk for Prostate Cancer
Dr. Mahmood Moshiri, President/CEO, Panacea Global Inc., Canada

15:10-15:30

Coffee Break


Track 3-2: MDx for Cancer

Time: 15:30-16:20, Dec. 3, 2012, (Sunday); Place: Room No. 3401, 4th Floor, Block 3, GZBICC

 

Chair

Dr. Mahmood Moshiri, President/CEO, Panacea Global Inc., Canada

Co-chair

Dr. Zhiyuan Hu, Director of Rapid Adoption Molecular Laboratory, University of North Carolina at Chapel Hill at Chapel Hill, USA

 

15:30-15:55

Title: Breast Cancer Biomarker Discovery by Whole Transcriptome RNA-Seq in Formalin-Fixed Paraffin-Embedded Tumor Tissue
Dr. Kunbin Qu, Director of Bioinformatics, Genomic Health, Inc., USA

15:55-16:20

Title: Prognostic Prediction of a 13-gene VEGF Signature in Breast Cancer
Dr. Zhiyuan Hu, Director of Rapid Adoption Molecular Laboratory, University of North Carolina at Chapel Hill, USA


Track 4: MDx in Pharmaceutical Industry and Healthcare

Topic 1: MDx in Drug Discovery and Development
Topic 2: MDx in Quality Control of Protein Therapeutics and Vaccines
Topic 3: MDx in Gene Therapy
Topic 4: MDx in Pharmaceutical Processing and Distribution
Topic 5: Molecular Diagnostics for Organ Transplantation
Topic 6: MDx in Molecular Epidemiology and Genetic Diseases
Topic 7: Role of Molecular Diagnostics in Future Healthcare

Topic 8: Therapy based on Molecular Diagnosis from Companion Test to POC Diagnostics

Track 4: MDx in Pharmaceutical Industry and Healthcare

Time: 08:30-10:30, Dec. 4, 2012, (Tuesday); Place: Room No. 3401, 4th Floor, Block 3, GZBICC

 

Chair

Dr. Pamela L. Swatkowski, Director, Abbott Molecular, Inc., USA

 

08:30-08:55

Title: Best Practices in Companion Diagnostics
Dr. Pamela L. Swatkowski, Director, Abbott Molecular, Inc., USA

08:55-09:20

Title: Rapid Raman Spectroscopy for Melanoma Screening
Dr. Thomas A Braun, CEO, Verisante Technology, Inc., Canada

09:20-09:45

Title: Evolution of the i-STAT Analyzer for DNA
Dr. Bruce Collier, Principal Research Scientist, Abbott Point of Care,Canada

09:45-10:10

Title:  The Economic Impact of Biomarker-based Testing within the Companion Diagnostics (Cdx)-Stratified Medicine Ecosystem
Dr. Alan K. Hauser, Executive Director, Bio-Com International, USA

10:10-10:30

Coffee Break


Track 5: Young Investigators’ Forum

Track 5: Young Investigators’ Forum

Time: 10:30-11:45, Dec. 4, 2012, (Tuesday); Place: Room No. 3401, 4th Floor, Block 3, GZBICC

 

Chair

Dr. Kestutis G. Bendinskas, Associate Professor, State University of New York at Oswego, USA

 

10:30-10:55

Title: Glutamate Dehydrogenase Activity in Cerebrospinal Fluid
Dr. Matej Kravos, Assistant professor, University of Maribor, Slovenia

10:55-11:20

Title: Lead, Mercury, Cortisol, and Inflammatory Proteins in Adolescents
Dr. Kestutis G. Bendinskas, Associate Professor, State University of New York at Oswego, USA

11:20-11:45

Title: Plasma Biomarkers of Abdominal Aortic Aneurysms
Dr. Saima Ehsan, Fellow, University of Leicester, UK

Hosting Organization

Operating Organization

BIT Congress Inc.
 
Foreign Experts Databank
of SAFEA-Dalian Biotechnological and Medical Experts Subdivision

Media Partners


© 2012-2013 All right reserved by BIT Congress Inc.
Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84796897